MPM BioImpact LLC, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), sold 437,830 shares at $1.22 ($533K) on 2025-11-05, disclosed to the SEC on 2025-11-06.
Scheduled sale ($533k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 140,488 | $171K | 32.2% |
| 2 | $1.22 | 140,488 | $171K | 32.2% |
| 3 | $1.22 | 47,950 | $58K | 11.0% |
| 4 | $1.21 | 54,452 | $66K | 12.4% |
| 5 | $1.21 | 54,452 | $66K | 12.4% |
| Total | $1.22 avg | 437,830 |
| $533K |
| 100% |
| Filing → |